Abstract . Cell surface tyrosine kinase receptors are subject to a rapid activation by their ligand, which is followed by secondary regulatory processes . The IHE2 cell line is a unique model system to study the regulation of EGF binding to EGF receptors after activation of the EGF receptor kinase. IHE2 cells express both a chimeric insulin-EGF receptor kinase (IER) and a kinase-deficient EGF receptor (HER K721A) . We have previously reported that IER is an insulin-responsive EGF receptor tyrosine kinase that activates one or several serine/threonine kinases, which in turn phosphorylate(s) the unoccupied HER K721A . In this article we show that insulin through IER activation induces a decrease in 'ZSI-EGF binding to IHE2 cells . Scatchard analysis indicates that, as for TPA, the effect of insulin can be accounted for by a loss of the high affinity bind-HE EGF receptor is a 170-kD transmembrane glycoprotein. The extracellular region contains the growth factor binding domain, whereas the intracellular re gion carries the tyrosine kinase catalytic domain (33, 38) . These two functions of the EGF receptor, i .e., EGF binding and tyrosine kinase activity, play cardinal roles in the induction of the EGF biological effects and are subject to fine regulatory mechanisms. Receptor tyrosine kinase activity is positively regulated by EGF binding, which leads to tyrosine phosphorylation of the receptor (15, 20, 21, 28) and of cellular substrates (38) . Recent data have indicated that tyrosine phosphorylation of the carboxy-terminal tail of the EGF receptor promotes the interaction with signaling molecules such as phospholipase C-.y and GTP-ase activating protein (GAP) ' (29) . In addition to these positive regulations, both the binding function and the kinase activity of the EGF receptor are subject to negative controls, which are mainly mediated by activation of protein kinase C. Thus, activators of protein kinase C, such as tetradecanoyl phorbol acetate (TPA) or PDGF, decrease the intrinsic tyrosine kinase ac- ing of EGF to HER K721A. Since this receptor transmodulation persists in protein kinase C downregulated IHE2 cells, it is likely to be due to a mechanism independent of protein kinase C activation. Using an in vitro system of 121 I-EGF binding to transmodulated IHE2 membranes, we illustrate that the inhibition of EGF binding induced by IER activation is related to the phosphorylation state of HER K721A. Further, studies with phosphatase 2A, or at a temperature (4°C) where only IER is functional, strongly suggest that the loss of high affinity EGF binding is related to the serine/ threonine phosphorylation of HER K721A after IER activation . Our results provide evidence for a "homologous desensitization" of EGF receptor binding after activation of the EGF receptor kinase of the IER receptor. tivity of the EGF receptor (7, 16, 17, 23) . The major EGF receptor site phosphorylated by protein kinase C appears to be threonine 654 (12, 22) . Studies using site-directed mutagenesis have shown that phosphorylation of the EGF receptor at threonine 654 is responsible for protein kinase C-induced inhibition of the receptor tyrosine kinase (11) . EGF binding is also altered by activation ofprotein kinase C (25, 34, 41), but the mechanism by which protein kinase C induces a loss ofhigh affinity binding sites on EGF receptor is not entirely elucidated. In fact, replacement of threonine 654 with an alanine residue (9, 11) or a tyrosine residue (27) does not affect regulation of EGF binding caused by TPA induced activation of protein kinase C. However, Lin et al. have reported that the phosphorylation of threonine 654 was required for the inhibition of EGF binding by TPA (26). A protein kinase C-independent mechanism has also been implicated in the regulation of the high affinity binding sites of the EGF receptor. Indeed, PDGF, interleukin l, and tumor necrosis factor are able to induce a loss of the high affinity binding sites in cells depleted of protein kinase C after a long-term TPA treatment (4, 9, 31) . This effect seems to be linked to the phosphorylation state of the EGF receptor (5, 13) . This heterologous receptor transmodulation provides a negative regulation of EGF-induced biological effects (33) .
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In a previous report, using a cell line expressing both a chimeric insulin-EGF tyrosine kinase receptor (IER) and a kinase-deficient EGF receptor (HER K72 IA), we have shown that the insulin-activated IER chimeric receptor phosphorylates the HER K721A on tyrosine residues (37) . In addition to this tyrosine transphosphorylation, insulin enhances the phosphorylation of HER K721A on serine/threonine residues. This implies that IER activates one or several serine/ threonine kinases, which in turn phosphorylates the unoccupied HER K721A. Those observations demonstrate the existence ofcross-talk between an unoccupied EGF receptor and a ligand-activated EGF receptor kinase (37) .
In this work, taking advantage ofthe same receptor model system, we investigated the regulation of EGF binding to the HER K721A after insulin-induced stimulation of the IER. We show that insulin through IER activation induces a decrease in EGF binding to IHE2 cells and, as for activation of protein kinase C, this effect can be accounted for by an inhibition of the high affinity binding of EGF to cell surface kinase-deficient EGF receptors. Since this receptor transmodulation persisted in IHE2 cells depleted of protein kinase C, it appears to be due to a mechanism independent of protein kinase C. Studies with phosphatase 2A, or at a temperature where virtually only tyrosine kinases are functional, strongly suggest that this inhibition of high affinity EGF binding is related to the serine/threonine phosphorylation of HER K721A after IER activation. In conclusion, we describe here an original "homologous desensitization" situation of the EGF receptor binding function after activation of the EGF receptor kinase of the IER receptor.
Materials and Methods
Mouse EGF "receptor grade" was from Sigma Chemical Co. (St . Louis, MO) and insulin was from Novo Nordisk Biolabs, Copenhagen, Denmark) . EGF was iodinated as described using the chloramine T method to a specific activity of 150 ACi/Ixg (19) . ["P]Orthophosphate was obtained from Amersham Corp. (Bucks, UK) . TPA, Triton X-100, protein A-Sepharose, and BSA (A7030) were from Sigma Chemical Co. All reagents for SDS-PAGE were from Bio-Rad Laboratories (Richmond, CA) . Antiphosphotyrosine antibodies were obtained by immunization of a sheep with phosphotyrosine coupled to bovine IgG and affinity-purified on a phosphotyrosine-agarose column (2) . mAb108 is a monoclonal antibody directed to the extracellular domain of the human EGF receptor (19) . Protein phosphalase 2A was a gift of P. Cohen (Department of Biochemistry, Medical Sciences Institute, University of Dundee, Dundee, UK) .
Cell Lines
Details concerning the generation and the culture of the IHE2 cell lines have been previously described (37) . In brief, IHE2 cells express both a kinasedeficient human EGF receptor, HER K721A, and a chimeric receptor IER composed of the extracellular domain of the human insulin receptor linked to the transmembrane and the cytosolic domain of the human EGF receptor. analyses, the cells were incubated for 3 h at 4°C with increasing concentrations of 125 1-EGF (from 10 to 3,000 pM) in the same binding medium .
Nonspecific binding was estimated in incubations containing a 100-fold excess of unlabeled EGF. Cells were rinsed two times with ice-cold PBS and solubilized in 0.2 N NaOH . The radioactivity was determined in a gammaradiation counter.
Preparation ofIHE2 Membranes
After being starved for 2 h in DME containing 0.2% BSA, IHE2 cells in 100-mm culture dishes were treated without and with insulin for 15 min at 37°C. The medium was aspirated and the cells were collected by scraping either in ice-cold buffer A (50 mM Hepes, pH 7.4, 150 mM NaCl, 1 mM EGTA, and protease inhibitors [100 U/ml aprotinin and 1 mM PMSF]) or in ice-cold buffer B, which contains in addition to buffer A, phosphatase inhibitors (50 mM Hepes, pH 7.4, 150 mM NaCl, 1 mM EGTA, 10 mM EDTA, 100 mM NaF, 2 mM vanadate, 10 mM Na4P207, and protease inhibitors [100 U/ml aprotinin and 1 mM PMSF]) . Thereafter, the cells were homogenized by 15 passages through a 26-gauge needle. The crude membrane preparation was obtained by centrifugation at 15,000 g for 15 min .
Binding of 125 1-EGF to IHE2 membranes was measured by incubation of 10-15 jig of membranes in 0 .3 ml of 50 mM Hepes, pH 7 .4, 150 mM NaCl, and 0.2% BSA in the presence of 0.1 nM 125 I-EGF and unlabeled EGF for the determination of the nonspecific binding . After 3 h of incubation at 4°C, the membranes were washed two times with PBS and counted .
31P-Labeling of Cells and Immunoblotting with AntiphosphotyrosineAntibodies
IHE2 cells were labeled with [" P]orthophosphate and HER K721A receptors isolated by inununoprecipitation with mAb108 and SDS-PAGE as described (37) . Immunoblotting analysis using anti-phosphotyrosine antibodies was performed as previously described (37) .
Protein Phosphatase 2A Treatment
Membranes from IHE2 cells exposed to insulin for 15 min were prepared in buffer B as described above. After two washes to remove phosphatase inhibitors, 10-15 wg of membranes were incubated in buffer C (150 mM NaCI, 5 mM Tris, pH 7.4, 1 mM EGTA, and protease inhibitors) in the presence of protein phosphatase 2A (10 U/ml final) at 30°C for 20 min . Control incubations were performed using protein phosphatase 2A inactivated with inhibitors (100 mM NaF and 10 mM Na4P207) . At the end of the treatment, the reaction was stopped by the addition of buffer B and the binding of 125 1-EGF to membranes was measured . In parallel to the binding studies, membranes from IHE2 cells or 32P-labeled IHE2 cells were processed and treated with protein phosphatase 2A as described above. Thereafter, membranes were solubilized for 15 min in buffer B containing I% Triton X-100 and receptors were obtained by immunoprecipitation with mAb108 prebound on protein A-Sepharose. Finally, receptors were subjected to SDS-PAGE . Unlabeled receptors were revealed by immunoblotting with antibodies to phosphotyrosine and 125 1-protein A, whereas 32p-labeled receptors were visualized by autoradiography.
Results
Effect ofInsulin and TPA on 121 I-EGF Binding to IHE2 Cells IHE2 cells expressing both the IER and the HER K721A were used to study the effect of insulin-activated IER on 125 1-EGF binding to HER K721A receptors. Confluent IHE2 cells were incubated at 37°C with insulin for increasing periods of time, and thereafter the binding of 125 1-EGF to cell surface receptors was measured at 4°C . Fig. 1 A shows that exposure of IHE2 cells to insulin caused a rapid decrease in the binding of 1251-EGF to kinase-deficient EGF receptors. Maximal inhibition (50% of the specific initial binding) was observed after 10 min of insulin treatment, and it remained constant up to 20 min ofinsulin stimulation. The time course of insulin-induced inhibition of EGF binding to anti-HER BINDING IHE2 cells was compared with that induced by TPA, which has been shown to decrease the high affinity EGF binding (25, 34) . No significant difference between the action of TPA and insulin on '21 1-EGF binding to IHE2 cells was observed ( Fig . 1 A) .
In Fig. 1 B we examined the number of cell surface kinasedeficient EGF receptors after 15 min of exposure to insulin. The number of receptors was estimated using a monoclonal antibody against the extracellular domain of the EGF receptor. We found that insulin did not change the number of immunoreactive HER K721A. These data suggest that the insulin-induced decrease in EGF binding to IHE2 cells cannot be accounted for by a decrease in the number of cell surface kinase-deficient EGF receptors. ScatchardAnalysis of 125I-EGF Binding to IHE2 Cells After Exposure to Insulin or TPA Given this unchanged receptor number we examined the possibility that the effect of insulin was due to a change in EGF receptor affinity as previously documented for TPA (25, 34) . Therefore, Scatchard analysis of 125 1-EGF binding to IHE2 cells treated for 15 min with insulin and TPA was performed (Fig. 2) . In control cells we obtained a curvilinear Scatchard plot, which has previously been interpreted to reflect the presence of two populations of binding sites (19, 24) , one in a high affinity state with a dissociation constant of -0.1 nM (5% of the sites) and a second one with a low affinity and a dissociation constant of -4 .9 nM (95 % of the sites) . Addition of TPA or insulin led to the virtually complete loss of the high affinity binding of EGF to the cell surface HER K72 1A . To further compare the action of insulin and TPA we investigated the effect of insulin on protein kinase C downregulated IHE2 cells. It has previously been documented that incubation of cultured cells with phorbol esters causes the downregulation of protein kinase C (31) . Confluent IHE2 cells were exposed to 1 p,M TPA for 24 h at 37°C in order to decrease protein kinase C activity (Fig . 3) . In comparison to control cells, acute TPA addition (15 min) to protein kinase C downregulated IHE2 cells did not lead to an inhibition of the high affinity 125I-EGF binding to HER K721A. In contrast, after 15 min of exposure, insulin decreased 'zsI-EGF binding to a similar extent in both control and TPApretreated cells. These results suggest that the mechanism by In a previous report we have shown that in IHE2 cells activation of the insulin-EGF chimeric receptor by insulin increases the tyrosine, serine, and threonine phosphorylation of the kinase-deficient EGF receptor (37) . To investigate the relationship between the phosphorylation state of HER K721A and its transmodulation by IER, we studied 121I-EGF binding to membranes from IHE2 cells exposed for 15 min to insulin . IHE2 membranes were prepared in either the absence or presence of phosphatase inhibitors. When insulin-stimulated IHE2 cells were used to prepare membranes in a buffer containing phosphatase inhibitors, we observed a 40% decrease in high affinity 1251-EGF binding to these membranes (Fig. 4) . In contrast, the effect ofinsulin was not found when the membrane fractions were isolated in the absence of phosphatase inhibitors. These data indicate that transmodulation of the kinase-deficient EGF receptor affinity by insulin-evoked IER activation was dependent on the receptor phosphorylation state. Upon exposure of IHE2 cells to insulin, HER K721A was phosphorylated on tyrosine, serine, and threonine residues (37) . Generally speaking, receptor tyrosine kinases have been found to retain activity at 4°C, while serine/threonine kinases show no or little activity at this temperature (1, 6) . Therefore, we performed binding and phosphorylation experiments at 4°C to determine whether tyrosine phosphorylation of HER K721A by IER was sufficient for induction of the decrease in high affinity EGF binding . The effect oftemperature on the ability of insulin to decrease '25 1-EGF binding to cell surface HER K721A receptors is illustrated in Fig .  5 A . Confluent IHE2 cells were incubated for 2 h either at 37°C or at 4°C, and thereafter exposed for 15 min to insulin . Finally, 1251-EGF binding to IHE2 cells was measured at 4°C. As described previously, at 37°C insulin decreased 1251-EGF binding to IHE2 cells (50% of inhibition) . However, at 4°C this decrease caused by insulin was totally absent. In a parallel experiment we also looked at the phosphorylation state of kinase-deficient EGF receptors. After 15 min of insulin stimulation either at 37 or 4°C, IHE2 cells were solubilized, HER K721A receptors were immunoprecipitated with mAb108 and analyzed by SDS-PAGE . Finally, the tyrosine-phosphorylated proteins were revealed by Western blotting with antibodies to phosphotyrosine . As shown in Fig. 5 B, activation ofIER receptors by insulin led to tyrosine transphosphorylation of HER K721A to a comparable extent at both 37 and 4°C. In IHE2 cells labeled with I32 p]orthophosphate, treatment by insulin at 37°C increased phosphorylation of HER K721A, but at 4°C no significant increase in phosphorylation of this receptor was detected .
Since we have previously shown that after 15 min of insulin stimulation HER K721A retained some phosphorylation on tyrosine residues with a predominant phosphorylation on serine and threonine residues (37), these data suggest that at 4°C only the tyrosine kinase of the insulin-EGF chimeric receptor was active and able to transphosphorylate the kinase-deficient EGF receptors . As a whole our data indicate that tyrosine transphosphorylation of the cell surface kinasedeficient EGF receptors is not sufficient for the induction of an insulin-mediated decrease in EGF receptor affinity. (1 mCi/ml) at 37°C for 2 h followed by 30 min at either 37 or 4°C, and finally for 15 min withoutor with 0.1 )AM insulin . After solubilization, the extracted proteins were precipitated with antibody to HER K721A and analyzed by SDS-PAGE. The gels of the experiment performed at 37 and at 4°C were dried and autoradiographed .
HER K72 1A was correlated with inhibition of EGF binding, we studied 125 1-EGF binding to transmodulated IHE2 membranes, which were treated with protein phosphatase 2A, a protein phosphatase considered to be specific for phosphoserine and phosphothreonine (8) . Fig . 6 A shows that when membranes from insulin-stimulated IHE2 cells were treated with protein phosphatase 2A, the high affinity EGF binding could be restored . Accordingly, the insulin-induced phosphorylation of HER K721A in 32P-labeled IHE2 cells disappeared by treatment of membranes with the phosphatase (Fig . 6 B) . It has been shown that, in addition to its welldocumented phosphatase activity toward phosphoserine and phosphothreonine, protein phosphatase 2A can exert in vitro a phosphotyrosine phosphatase activity (8, 18) . To investigate this possibility we probed the protein phosphatase 2A-treated membranes with antibodies to phosphotyrosine . The immunoblot shows that under our experimental conditions the protein phosphatase 2A did not remove phosphate from phosphotyrosine residues (Fig. 6 B) . Hence dephosphorylation of phosphoserine and phosphothreonine residues on HER K721A suffices for the restoration of the high affinity EGF binding to IHE2 membranes. Control incubations were performed with protein phosphatase 2A inactivated by 100 mM NaF and 10 mM Na,P20, . Thereafter, the binding of 125 1-EGF to membranes was measured as described in the legend to Fig . 4. (B) Membranes from IHE2 cells or 32P-labeled IHE2 cells were treated with protein phosphatase 2A as described above. Thereafter, membranes were solubilized and HER K721A were obtained by immunoprecipitation with mAbl08 and analyzed by SDS-PAGE . Unlabeled receptors were analyzed by immunoblotting with antibodies to phosphotyrosine . The gel with 32p labeled receptors was dried and exposed to film . PP2A, protein phosphatase 2A .
Discussion
Taking advantage of IHE2 cells, we have studied the regulation of EGF binding to EGF receptors after activation of a serine/threonine kinase linked to the EGF receptor. IHE2 cells express both a chimeric insulin-EGF receptor kinase (IER) and a kinase-deficient EGF receptor (HER K721A) .
We have shown in a previous report that IER is an insulinresponsive EGF receptor tyrosine kinase, which phosphorylates the unoccupied HER K721A on tyrosine residues . Further, after IER activation HER K721A is phosphorylated on serine and threonine residues by one or several serine/threonine kinases (37) .
Here we demonstrate that treatment of IHE2 cells with insulin results in a reduction in EGF binding to HER K721A . The maximal decrease in EGF binding (50% of initial binding) is seen after 10 min of insulin treatment and is very similar to the one observed with TPA . Scatchard analysis indicates that, as for TPA, the effect of insulin on EGF binding occurs via a reduction in high affinity binding sites of EGF to cell surface HER K721A without detectable change in receptor number. However, in protein kinase C downregulated IHE2 cells, the effect of insulin through IER activation persists on EGF binding . Hence we would like to conclude that the transmodulation of EGF binding caused by insulin is due to a mechanism distinct from that used by TPA, and appears thus to be independent of protein kinase C activation. Further, using IER cells transfected only with the chi-meric receptor, we show that insulin decreases the binding of EGF to wild-type endogenous EGF receptor, indicating that native EGF receptors are transmodulated upon IER activation.
Two series of observations led us to investigate the role of the EGF receptor phosphorylation state in the transmodulation induced by insulin-activated IER : (a) the EGF receptor phosphorylation on serine and threonine residues appears to play a role in regulation of receptor functions (33, 35) , and (b) in IHE2 cells we have previously shown that upon 15 min of insulin stimulation, HER K721A is phosphorylated predominantly on serine and threonine residues (37) . Therefore, we studied the relationship between the phosphorylation state of HER K721A and the loss ofhigh affinity binding sites using an in vitro system of EGF binding to transmodulated IHE2 membranes . In these experiments, membranes must be isolated in the presence of phosphatase inhibitors to preserve the decrease in high affinity binding sites induced by insulin . This indicates that inhibition of the high affinity binding sites ofHER K72 IA induced by IER activation is dependent on the receptor phosphorylation state. Studies at 4°C illustrate that tyrosine phosphorylation of the cell surface HER K721A by IER is not a sufficient signal to induce the loss of high affinity binding sites. In fact, at 4°C this transregulation is not detected, while insulin induces tyrosine transphosphorylation ofHER K721A to the same extent at both 37 and 4°C. In additional experiments we found that dephosphorylation on phosphoserine and phosphothreonine induced by treatment of transmodulated membranes with protein phosphatase 2A can completely restore the high affinity EGF binding . These data indicate that the inhibition ofEGF binding results from the serine/threonine phosphorylation of the EGF receptor .
As a whole, our results strongly suggest that IER activation stimulates at least one serine/threonine kinase distinct from protein kinase C, which in turn phosphorylates the unoccupied HER K721A and consequently alters its affinity for EGF. Two very recent studies have reported that members of the mitogen-activated protein kinase family are able to phosphorylate the EGF receptor on threonine 669 (30, 36) . However, we do not favor the idea that a kinase with such a specificity could be involved in the phenomena described in our study, since substitution of threonine 669 by sitedirected mutagenesis has shown that the phosphorylation of this residue is not required for the modulation of EGF binding caused by TPA and PDGF (10) .
The homologous EGF receptor transmodulation observed in IHE2 cells is, at least in two respects, similar to the transregulation of EGF receptor induced by heterologous stimuli such as PDGF, interleukin 1, and tumor necrosis factor (4, 5, 9, 13, 31) . First, both phenomena can occur in protein kinase C-deficient cells, and second, they are related to the serine/threonine phosphorylation state of the receptor .
Whiteley and Glaser previously reported a possible homologous regulation of the EGF receptor (39) . However, it appears to be different from the one we observed in our study for the following reasons . The desensitization described by these authors is mediated by activation of protein kinase C, which phosphorylates the EGF receptor at threonine residue 654. Phosphorylation of the EGF receptor on this site is thought to regulate the receptor kinase activity, but not the binding parameters of EGF receptors (11, 27) . Additionally, The Journal of Cell Biology, Volume 116, 1992 in the report of Whiteley and Glaser only 40% of the EGF receptors are phosphorylated on threonine 654, whereas in our study we found a complete disappearance of the high affinity binding sites . Since it has been proposed that EGF receptor signal transduction occurs predominantly through this particular population ofhigh affinity EGF receptors (3, 14) , we would like to suggest that the homologous desensitization we illustrate here plays a pivotal role in attenuation of EGF signaling .
The mechanism by which EGF receptor phosphorylation affects its binding parameters could be explained at least by the two following hypotheses : (a) phosphorylation on serine/threonine residues ofthe cytoplasmic domain ofthe EGF receptor could cause a conformational change that is propagated to the extracellular domain and results in the loss of the high affinity binding sites ; and (b) phosphorylation of the EGF receptor on serine/threonine residues could induce association of the receptor with a cellular component, as has previously been described for rhodopsin and arrestin (40) . This interaction would lead to the disappearance of the high affinity binding sites . However, we cannot rule out the possibility that the key event in the process leading to the loss of high affinity binding sites is the phosphorylation by a serine/threonine kinase of a cellular component, which in turn interacts with the EGF receptor and decreases the receptor affinity.
In summary, using a model system consisting ofachimeric insulin-EGF receptor and a kinase-deficient EGF receptor we have shown the occurrence of homologous desensitization of the EGF receptor binding function. We would like to suggest that a similar phenomenon also exists among genuine EGF receptors, and provides a newly identified negative feedback loop of EGF receptor regulation. Desensitization of EGF receptor binding in concert with protein kinase C-induced attenuation of the receptor tyrosine kinase could represent an efficient mechanism for limiting the amplitude and duration of the EGF mitogenic response .
